Dr. Mulvaney published the first study showing that bilateral SGBs resulted in 50% improvement of TBI symptoms. The Successful Use of Bilateral 2-Level Ultrasound-Guided Stellate Ganglion Block to Improve Traumatic Brain Injury Symptoms: A Retrospective Analysis of 23 Patients

The first multi-centered randomized clinical trial showing efficacy of SGB for PTSD published in a major journal. Effect of the Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms-A Randomized Clinical Trial. JAMA Psychiatry 2019

The first study of its kind showing that SGB treatment for PTSD can improve global neurocognitive function. Neurocognitive Performance is Not Degraded After Stellate Ganglion Block Treatment. Military Medicine 2015

The first study demonstrating successful treatment of Anxiety with SGB and the benefit of a bilateral SGB over a single side.  Stellate Ganglion Block Reduces Anxiety Symptoms by Half: A Case Series of 285 Patients. Journal of Personalized Medicine 2023